@seedy19tron "despite significant drawdowns" is not an insignificant detail that should be glossed over with a minor asterisk. Funds are paid to smooth out volatility. By design, running family office vs institutional money will never be the same. Cross-comparing results thus not relevant
@TheBiotechBear I think LOs are underrated. Bespoke and tailored research process where you can spend weeks, days, months even on a single name. Helps to filter out all the day to day noise happening in markets when you have the freedom of deep research and long investment horizons.
Funniest freeware resource to me is that the @stock_analysisx site is surprisingly robust given its name sounds like a high schooler's summer project idea
$ABVX Congratulations to Abivax! All of our shareholders are becoming future patients.
It’s called stress induced IBS.
We are winning like never before!
Thank you for your attention to this matter.
- MDG